In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 289.2 | 218.5 | 288.1 | 359.4 | 323.8 | 283.8 | 355.2 | 333.0 | 324.4 | 296.4 | 290.7 | 310.5 | |
| Other Income | 0.3 | 0.7 | 0.4 | 0.3 | 0.6 | 1.1 | 0.8 | 0.8 | 0.4 | 0.9 | 2.1 | 0.7 | |
| Total Income | 289.5 | 219.2 | 288.5 | 359.7 | 324.4 | 285.0 | 356.0 | 333.9 | 324.8 | 297.3 | 292.7 | 311.3 | |
| Expenses | |||||||||||||
| + Cost of Materials Consumed | 7.1 | 307.2 | 531.1 | 42.8 | 10.0 | 326.9 | 470.1 | 17.2 | 33.9 | 278.0 | 493.3 | 26.0 | |
| + Purchases of Stock-in-Trade | 0.0 | 0.0 | 0.0 | 4.8 | -0.0 | 1.8 | 1.9 | 1.7 | 1.8 | 2.7 | 1.7 | 1.5 | |
| + Changes in Inventories | 213.3 | -198.3 | -388.3 | 234.8 | 249.6 | -146.8 | -291.0 | 257.2 | 245.5 | -91.1 | -342.1 | 245.0 | |
| + Employee Benefit Expense | 13.2 | 17.1 | 19.4 | 14.7 | 14.8 | 17.4 | 19.9 | 15.0 | 15.8 | 17.7 | 20.9 | 15.7 | |
| + Finance Costs | 6.6 | 3.5 | 11.2 | 13.1 | 7.4 | 5.1 | 12.8 | 12.2 | 8.2 | 4.9 | 10.2 | 9.9 | |
| + Depreciation & Amortisation | 6.3 | 6.4 | 6.4 | 6.5 | 6.6 | 7.0 | 7.3 | 7.4 | 7.7 | 7.8 | 6.9 | 7.8 | |
| + Other Expenses | 22.5 | 31.2 | 45.4 | 27.0 | 28.6 | 45.2 | 38.9 | 22.9 | 25.5 | 40.9 | 39.0 | 21.6 | |
| Total Expenses | 269.0 | 167.1 | 225.3 | 343.8 | 317.0 | 256.7 | 259.8 | 333.6 | 338.5 | 260.8 | 229.7 | 327.6 | |
| EBITDA | 33.2 | 61.3 | 80.4 | 35.3 | 20.9 | 39.3 | 115.4 | 19.1 | 1.8 | 48.3 | 78.0 | 0.7 | |
| EBIT | 26.8 | 55.0 | 74.0 | 28.7 | 14.3 | 32.3 | 108.1 | 11.7 | -5.9 | 40.5 | 71.1 | -7.1 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | 20.5 | 52.1 | 63.1 | 15.9 | 7.4 | 28.3 | 96.2 | 0.3 | -13.7 | 36.5 | 63.0 | -16.3 | |
| + Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.6 | 0.7 | 0.0 | |
| Pretax Income | 20.5 | 52.1 | 63.1 | 15.9 | 7.4 | 28.3 | 96.2 | 0.3 | -13.7 | 34.9 | 63.7 | -16.3 | |
| + Current Tax | 5.3 | 14.5 | 17.4 | 4.8 | 2.6 | 7.8 | 16.6 | 0.0 | 0.0 | 4.4 | 13.4 | 0.0 | |
| + Deferred Tax | 0.2 | -1.3 | -1.2 | -0.3 | -0.6 | -0.6 | 8.1 | 0.0 | -3.3 | 5.5 | 1.8 | -4.1 | |
| Tax Expense | 5.5 | 13.2 | 16.3 | 4.5 | 2.0 | 7.1 | 24.7 | 0.0 | -3.3 | 9.8 | 15.2 | -4.1 | |
| Net Income | 15.1 | 38.9 | 46.9 | 11.4 | 5.4 | 21.1 | 71.5 | 0.2 | -10.4 | 25.1 | 48.6 | -12.2 | |
| + Net Income — Continuing Ops | 15.1 | 38.9 | 46.9 | 11.4 | 5.4 | 21.1 | 71.5 | 0.2 | -10.4 | 25.1 | 48.6 | -12.2 | |
| + Other Comprehensive Income | 0.0 | 0.0 | -0.3 | -0.0 | -0.0 | -0.0 | 0.1 | -0.0 | -0.0 | -0.0 | 0.4 | -0.0 | |
| Total Comprehensive Income | 15.1 | 38.9 | 46.5 | 11.4 | 5.3 | 21.1 | 71.6 | 0.2 | -10.4 | 25.1 | 48.9 | -12.2 | |
| Per Share | |||||||||||||
| Basic EPS | 10.70 | 27.61 | 33.27 | 8.11 | 3.81 | 15.00 | 50.75 | 0.16 | -7.35 | 17.80 | 34.46 | -8.67 | |
| Diluted EPS | 10.70 | 27.61 | 33.27 | 8.11 | 3.81 | 15.00 | 50.75 | 0.16 | -7.35 | 17.80 | 34.46 | -8.67 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | 0.1 | -0.0 | -0.0 | -0.0 | 0.4 | -0.0 | |
| + Items NOT to be Reclassified to P&L | 0.0 | 0.0 | -0.5 | -0.0 | -0.0 | -0.0 | 0.1 | -0.0 | -0.0 | -0.0 | 0.5 | -0.0 | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | 0.0 | -0.0 | -0.0 | -0.0 | 0.1 | -0.0 | |
| + Tax on Items NOT to be Reclassified — alt tag | 0.0 | 0.0 | -0.1 | -0.0 | -0.0 | -0.0 | — | — | — | — | — | — | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 10.70 | 27.61 | 33.27 | 8.11 | 3.81 | 15.00 | 50.75 | 0.16 | -7.35 | 17.80 | 34.46 | -8.67 | |
| Diluted EPS — Continuing Operations | 10.70 | 27.61 | 33.27 | 8.11 | 3.81 | 15.00 | 50.75 | 0.16 | -7.35 | 17.80 | 34.46 | -8.67 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 2.5 | — | 0.5 | — | 0.8 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 68.8 | 109.6 | 145.3 | 77.0 | 64.3 | 101.9 | 174.3 | 56.9 | 43.1 | 106.9 | 137.8 | 38.0 | |
| Gross Margin % | 23.80 | 50.14 | 50.41 | 21.42 | 19.84 | 35.91 | 49.06 | 17.10 | 13.30 | 36.05 | 47.40 | 12.24 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | 20.5 | 52.1 | 63.1 | 15.9 | 7.4 | 28.3 | 96.2 | 0.3 | -13.7 | 36.5 | 63.0 | -16.3 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.6 | 0.7 | 0.0 | |
| Net Income Adj (tax-effected) | 15.1 | 38.9 | 46.9 | 11.4 | 5.4 | 21.1 | 71.5 | 0.2 | -10.4 | 26.2 | 48.0 | -12.2 | |
| EPS Adj | 10.70 | 27.61 | 33.27 | 8.11 | 3.81 | 15.00 | 50.75 | 0.16 | -7.35 | 18.60 | 34.07 | -8.67 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | 14.1 | |